Vehicles based on a sugar surfactant: Colloidal structure and its impact on in vitro/in vivo hydrocortisone permeation

International Journal of Pharmaceutics

Volumn 320, Issue 1-2, 2006, Pages 86-95

  Savić, Snežana D ^a   Savić, Miroslav M ^a   Vesić, Sonja A ^b   Vuleta, Gordana M ^a   Müller Goymann, Christel C ^c  

^a Faculty of Pharmacy   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

Author keywords

Alkylpolyglucosides; Hydrocortisone; In vitro in vivo permeation; Interlamellar water; Lamellar gel phase liquid crystals

Indexed keywords

CETEARYL GLUCOSIDE; CETOSTEARYLIC ALCOHOL; DRUG VEHICLE; GLUCOSIDE; HYDROCORTISONE; UNCLASSIFIED DRUG; WATER OIL CREAM;

ADULT; ARTICLE; BLOOD RHEOLOGY; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG PENETRATION; FEMALE; HUMAN; HUMAN EXPERIMENT; HYDRATION; NORMAL HUMAN; PHYSICAL CHEMISTRY; POLARIZATION MICROSCOPY; PRIORITY JOURNAL; SKIN WATER LOSS; STRATUM CORNEUM; THERMAL ANALYSIS; THERMODYNAMICS; THERMOGRAVIMETRY; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION;

EID: 33746465773     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2006.04.019     Document Type: Article

References (48)

1. Adams, W.P., Singh, G.J.P., 1995. Guidance: Topical Dermatologic Corticosteroids: In Vivo Bioequivalence. Division of Bioequivalence, Office of Generic Drugs, Food and Drug Administration.
2. Ashton P., Walters K.A., Brain K.R., and Hadgraft J. Surfactant effects in percutaneous absorption. Part II. Effects on protein and lipid structure of the stratum corneum. Int. J. Pharm. 87 (1992) 265-269
3. Bach M., and Lippold B.C. Percutaneous penetration enhancement and its quantification. Eur. J. Pharm. Biopharm. 46 (1998) 1-13
4. Bárány E., Lindberg M., and Lodén M. Unexpected skin barrier influence from nonionic emulsifiers. Int. J. Pharm. 195 (2000) 189-195
5. Barry B.W., and Bennet S.L. Effect of penetration enhancers on the permeation of mannitol, hydrocortisone and progesterone through human skin. J. Pharm. Pharmacol. 39 (1987) 535-546
6. Berardesca E. EEMCO guidance for the assessment of stratum corneum hydration: electrical methods. Skin Res. Technol. 3 (1997) 126-132
7. Brinkmann I., and Müller-Goymann C.C. Role of isoprpyl myristate, isopropyl alcohol and a combination of both in hydrocortisone permeation across the human stratum corneum. Skin Pharmacol. Appl. Skin Physiol. 16 (2003) 393-404
8. Brinon L., Geiger S., Alard V., Doucet J., Tranchant J.F., and Couarraze G. Percutaneous absorption of sunscreens from liquid crystalline phases. J. Control. Release 60 (1999) 67-76
9. Carr M.G., Corish J., and Corrigan O.I. Drug delivery from a liquid crystalline base across Visking and human stratum corneum. Int. J. Pharm. 157 (1997) 35-42
10. ® . Skin Res. Technol. 6 (2000) 230-238
11. Cross S.E., Pugh W.J., Hadgraft J., and Roberts M.S. Probing the effect of vehicles on topical delivery: understanding the basic relationship between solvent and solute penetration using silicone membranes. Pharmacol. Res. 18 (2001) 999-1005
12. Csóka I., Csanyi E., Zapantis G., Nagy E., Fehér-Kiss A., Horváth G., Blazsó G., and Ero{combining double acute accent}s I. In vitro and in vivo percutaneous absorption of topical dosage forms: case studies. Int. J. Pharm. 291 (2005) 11-19
13. Eccleston G.M., Behan-Martin M.K., Jones G.R., and Towns-Andrews E. Synchrotron X-ray investigations into the lamellar gel phase formed in pharmaceutical creams prepared with cetrimide and fatty alcohols. Int. J. Pharm. 203 (2000) 127-139
14. Fairhust C.E., Fuller S., Gray J., and Holmes M.C. Lyotropic surfactant liquid crystals. In: Demus D., Goodby J., Gray G.W., Spiess H.W., and Vill V. (Eds). Handbook of Liquid Crystals vol. 3 (1998), Wiley-VCH, Weinheim 341-392
15. Farkas E., Zelko R., Nemeth Z., Palinkas J., Marton S., and Racz I. The effect of liquid crystalline structure on chlorhexidine diacetate release. Int. J. Pharm. 193 (2000) 239-245
16. Fullerton A., Fischer T., Lahti A., Wilhelm K.P., Takiwaki H., and Serup J. Guidelines for measurement of skin colour and erythema. A report from the Standardization Group of the European Society of Contact Dermatitis. Contact Dermatitis 35 (1996) 1-10
17. Gay C.L., Guy R.H., Golden G.M., Mak V.H.W., and Francoeur M.L. Characterization of low-temperature (i.e., <65 °C) lipid transitions in human stratum corneum. J. Invest. Dermatol. 103 (1994) 233-239
18. Ghadially R., Halkier-Sorensen L., and Elias P.M. Effects of petrolatum on stratum corneum structure and function. J. Am. Acad. Dermatol. 26 (1992) 387-396
19. Gloor M., and Gehring W. O/W emulsions compromise the stratum corneum barrier and improve drug penetration. Pharmazie 58 (2003) 709-715
20. Haigh J.M., Meyer E., Smith E.W., and Kanfer I. The human skin blanching assay for in vivo topical corticosteroid assessment. Part I. Reproducibility of the assay. Int. J. Pharm. 152 (1997) 179-183
21. Junginger H.E. Multiphase emulsions. In: Rieger M.M., and Rhein L.D. (Eds). Surfactants in Cosmetics (1997), Marcel Dekker, New York 155-182
22. Lehmann L., Keipert S., and Gloor M. Effects of microemulsions on the stratum corneum and hydrocortisone penetration. Eur. J. Pharm. Biopharm. 52 (2001) 129-136
23. Levin J., and Maibach H. The correlation between transepidermal water loss and percutaneous absorption: an overview. J. Control. Release 103 (2005) 291-299
24. Lodén M., Andersson A.C., Frödin T., Öman H., and Lindberg M. Instrumental and dermatologist evaluation of the effect of glycerine and urea on dry skin in atopic dermatitis. Skin Res. Technol. 7 (2001) 209-213
25. Makai M., Csanyi E., Nemeth Z., Palinkas J., and Ero{combining double acute accent}s I. Structure and drug release of lamellar liquid crystals containing glycerol. Int. J. Pharm. 256 (2003) 95-107
26. Mao-Qiang M., Brown B.E., Wu-Pong S., Feingold K.R., and Elias P.M. Exogenous nonphysiologic vs. physiologic lipids. Divergent mechanisms for correction of permeability barrier dysfunction. Arch. Dermatol. 131 (1995) 809-816
27. Müller-Goymann C.C. Drug delivery-liquid crystals. In: Swarbrick J., and Boylan J.C. (Eds). The Encyclopedia of Pharmaceutical Technology, vol. 1 (2002), Marcel Dekker, New York 834-853
28. Müller-Goymann C.C., and Alberg U. Modified water content containing hydrophilic ointment with suspended hydrocortisone-21-acetate - the influence of the microstructure of the cream on the in vitro drug release and in vivopercutaneous penetration. Eur. J. Pharm. Biopharm. 47 (1999) 139-143
29. Müller-Goymann C.C., and Frank S.G. Interaction of lidocaine and lidocaine-HCl with the liquid crystal structure of topical preparations. Int. J. Pharm. 29 (1986) 147-159
30. Nesseem D.I. Formulation and evaluation of itraconazole via liquid crystal for topical delivery system. J. Pharm. Biomed. Anal. 26 (2001) 387-399
31. Niedner, N., Ziegenmeyer, J., 1992. Dermatika, Wissenschaftliche Verlagsgesellschaft, Stuttgart.
32. Ponec M. Skin constucts for replacement of skin tissues for in vitro testing. Adv. Drug Deliv. Rev. 54 (2002) S19-S30
33. Refai H., and Müller-Goymann C.C. The influence of dilution of topical semisolid preparations on hydrocortisone permeation through excised human stratum corneum. Eur. J. Pharm. Biopharm. 54 (2002) 143-150
34. Robles-Vasquez O., Corona-Galvan S., Soltero J.F.A., Puig J.E., Tripodi S.B., Valles E., and Manero O. Rheology of lyotropic liquid crystals of Aerosol OT. Part II. High concentration regime. J. Colloid Interface Sci. 160 (1993) 65-71
35. Rogiers V., and EEMCO Group. EEMCO guidance for the assessment of transepidermal water loss in cosmetic sciences. Skin Pharmacol. Appl. Skin Physiol. 14 (2001) 117-128
36. Savic S., Tamburic S., Savic M., Cekic N., Milic J., and Vuleta G. Vehicle-controlled effect of urea on normal and SLS-irritated skin. Int. J. Pharm. 271 (2004) 269-280
37. Savic S., Vuleta G., Daniels R., and Müller-Goymann C.C. Colloidal microstructure of binary systems and model creams stabilized with an alkylpolyglucoside non-ionic emulsifier. Colloid Polym. Sci. 283 (2005) 439-451
38. Schmook F.P., Meingassner J.G., and Billich A. Comparison of human skin or epidermis models with human and animal skin in in vitro percutaneous absorption. Int. J. Pharm. 215 (2001) 51-56
39. Schwarb F.P., Imanidis G., Smith E.W., Haigh J.M., and Surber C. Effect of concentration and degree of saturation of topical fluocinonide formulations on in vitro membrane transport and in vivo availability on human skin. Pharm. Res. 16 (1999) 909-915
40. Specht C., Stoye I., and Müller-Goymann C.C. Comparative investigations to evaluate the use of organotypic cultures of transformed and native dermal and epidermal cells for permeation studies. Eur. J. Pharm. Biopharm. 46 (1998) 273-278
41. Stubenrauch C. Sugar surfactants - aggregation, interfacial, and adsorption phenomena. Cur. Opin. Colloid Interface Sci. 6 (2001) 160-170
42. Suhonen T.M., Bouwstra J.A., and Urtti A. Chemical enhancement of percutaneous absorption in relation to stratum corneum structural alterations. J. Control. Release 59 (1999) 149-161
43. Takiwaki H., Miyaoka Y., Kohno H., and Arase S. Graphic analysis of the relationship between skin colour change and variations in the amounts of melanin and haemoglobin. Skin Res. Technol. 8 (2002) 78-83
44. Wang Y.Y., Hong C.T., Chiu W.T., and Fang J.Y. In vitro and in vivo evaluations of topically applied capsaicin and nonivamide from hydrogels. Int. J. Pharm. 224 (2001) 98-104
45. Wilisch I.L., and Müller-Goymann C.C. Correlation of colloidal microstructure, drug release and permeation through excised human skin. Int. J. Pharm. 96 (1993) 79-84
46. Williams A.C., and Barry B.B. Penetration enhancers. Adv. Drug Deliv. Rev. 56 (2004) 603-618
47. Winkler A., and Müller-Goymann C.C. Comparative permeation studies for δ-aminolevulinic acid and its n-butyl ester through stratum corneum and artificial skin constructs. Eur. J. Pharm. Biopharm. 53 (2002) 281-287
48. Zhai H., and Maibach H.I. Effects of skin occlusion on percutaneous absorption: an overview. Skin Pharmacol. Appl. Skin Physiol. 14 (2001) 1-10